Overview

A Study of Dulaglutide in Japanese Participants With Type 2 Diabetes

Status:
Completed
Trial end date:
2018-06-18
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to evaluate the efficacy and safety of combination therapy with dulaglutide and insulin in Japanese participants with type 2 diabetes.
Phase:
Phase 4
Details
Lead Sponsor:
Eli Lilly and Company
Treatments:
Dulaglutide
Immunoglobulin Fc Fragments